← Back to headlines
Pfizer Stock Performance Tied to New Drugs vs. Old Patents
The future performance of Pfizer stock is being analyzed as a race between the success of its new drug pipeline and the expiration of its older patents.
20 Aug, 16:54 — 20 Aug, 16:54
Sources
Showing 1 of 1 sources
Related Stories
Anthropic Secures $35 Billion Cloud Computing Agreement With Lambda
17m ago
Bank of England Governor Warns AI Poses Threat to Global Financial Stability
27m ago
John Ternus Appointed New Chief Executive Officer at Apple
1h ago
Australian Judge Considers Granting Expert Access to Tesla Engineering Data
1h ago